JohnAVestMD
Cardiology • New York, NYCardiac Electrophysiology
Assistant Professor, Medicine, Columbia University College of Phys & Surg
Are you Dr. Vest?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
New York Presbyterian Hospital
630 West 168th Street, Ph3-347
New York, NY 10032Phone+1 212-305-8194
Summary
- Dr. John Vest, MD is a cardiologist in New York, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor at Columbia University College of Phys & Surg.
Education & Training
Brigham and Women's Hospital/West Roxbury Veterans Affairs Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2006 - 2007
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2002 - 2006- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
NY State Medical License 1999 - 2012
Clinical Trials
- HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- 262 citationsRyanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.Xander H.T. Wehrens, Stephan E. Lehnart, Steven Reiken, John A. Vest, Anetta Wronska
Proceedings of the National Academy of Sciences of the United States of America. 2006-01-17 - 59 citationsAssociation of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.Masatoshi Minamisawa, Brian Claggett, David Adams, Arnt V. Kristen, Giampaolo Merlini
JAMA Cardiology. 2019-05-01 - 223 citationsEffects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated AmyloidosisScott D. Solomon, David Adams, Arnt V. Kristen, Martha Grogan, Alejandra González-Duarte
Circulation. 2019-01-22
Press Mentions
Alnylam Announces New Data from ATTR Amyloidosis Programs at the Peripheral Nerve Society’s 2021 Annual MeetingJune 7th, 2021- FDA Panel Supports Patisiran for ATTR Amyloidosis with CardiomyopathySeptember 15th, 2023
